JP2005539049A5 - - Google Patents

Download PDF

Info

Publication number
JP2005539049A5
JP2005539049A5 JP2004532905A JP2004532905A JP2005539049A5 JP 2005539049 A5 JP2005539049 A5 JP 2005539049A5 JP 2004532905 A JP2004532905 A JP 2004532905A JP 2004532905 A JP2004532905 A JP 2004532905A JP 2005539049 A5 JP2005539049 A5 JP 2005539049A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
tetrahydro
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004532905A
Other languages
English (en)
Japanese (ja)
Other versions
JP4554364B2 (ja
JP2005539049A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/025782 external-priority patent/WO2004020435A1/en
Publication of JP2005539049A publication Critical patent/JP2005539049A/ja
Publication of JP2005539049A5 publication Critical patent/JP2005539049A5/ja
Application granted granted Critical
Publication of JP4554364B2 publication Critical patent/JP4554364B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004532905A 2002-08-16 2003-08-15 インテグリンと選択的に結合するピペリジニル化合物 Expired - Fee Related JP4554364B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40423902P 2002-08-16 2002-08-16
PCT/US2003/025782 WO2004020435A1 (en) 2002-08-16 2003-08-15 Piperidinyl compounds that selectively bind integrins

Publications (3)

Publication Number Publication Date
JP2005539049A JP2005539049A (ja) 2005-12-22
JP2005539049A5 true JP2005539049A5 (https=) 2006-06-29
JP4554364B2 JP4554364B2 (ja) 2010-09-29

Family

ID=31978252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004532905A Expired - Fee Related JP4554364B2 (ja) 2002-08-16 2003-08-15 インテグリンと選択的に結合するピペリジニル化合物

Country Status (24)

Country Link
US (1) US20040077684A1 (https=)
EP (1) EP1539739B1 (https=)
JP (1) JP4554364B2 (https=)
KR (1) KR20050031464A (https=)
CN (1) CN100506815C (https=)
AR (1) AR041010A1 (https=)
AT (1) ATE489378T1 (https=)
AU (2) AU2003259891A1 (https=)
BR (1) BR0313534A (https=)
CA (1) CA2496127C (https=)
CR (1) CR7692A (https=)
CY (1) CY1111194T1 (https=)
DE (1) DE60335118D1 (https=)
DK (1) DK1539739T3 (https=)
ES (1) ES2355139T3 (https=)
IL (1) IL166534A (https=)
MX (1) MXPA05001859A (https=)
NO (1) NO332036B1 (https=)
PL (1) PL219749B1 (https=)
PT (1) PT1539739E (https=)
RU (1) RU2333210C2 (https=)
SI (1) SI1539739T1 (https=)
UA (1) UA83467C2 (https=)
WO (1) WO2004020435A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224986A1 (en) 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
US7351711B2 (en) 2003-07-31 2008-04-01 Janssen Pharmaceutical, N.V. Tricyclic indanyls as integrin inhibitors
ES2671522T3 (es) * 2004-04-02 2018-06-06 The Regents Of The University Of California Métodos y composiciones para tratar y prevenir una enfermedad asociada con la integrina alfa V beta 5
EP1830902A2 (en) * 2004-12-30 2007-09-12 Cinvention Ag Combination comprising an agent providing a signal, an implant material and a drug
CN101272808B (zh) * 2005-01-06 2012-03-21 通用电气医疗集团股份有限公司 光学成像
US8636995B2 (en) * 2006-08-31 2014-01-28 Cardiac Pacemakers, Inc. Methods and devices to regulate stem cell homing
US8372399B2 (en) * 2006-08-31 2013-02-12 Cardiac Pacemakers, Inc. Bispecific antibodies and agents to enhance stem cell homing
US20080058922A1 (en) * 2006-08-31 2008-03-06 Cardiac Pacemakers, Inc. Methods and devices employing vap-1 inhibitors
PT2178858E (pt) 2007-08-02 2012-02-24 Recordati Ireland Ltd Novos compostos heterocíclicos como antagonistas de mglu5
ES2474165T3 (es) 2007-10-30 2014-07-08 Janssen Pharmaceutica N.V. Proceso enantioselectivo para preparar un ácido alcanoico sustituido
ES2457822T3 (es) * 2007-11-08 2014-04-29 The General Hospital Corporation Procedimientos y composiciones de tratamiento de enfermedades proteinúricas
CA2767409C (en) 2009-07-24 2018-10-30 The Regents Of The University Of California Methods and compositions for treating and preventing disease associated with .alpha.v.beta.5 integrin
PL3050878T3 (pl) 2013-09-24 2022-01-24 Fujifilm Corporation Zawierający atom azotu związek lub jego sól, lub ich kompleks z metalem
JP2019530678A (ja) 2016-09-18 2019-10-24 エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド Yap1のoct4との相互作用を標的とするyap1阻害剤
MX2019005234A (es) * 2016-11-08 2019-08-12 Squibb Bristol Myers Co Amidas y aminas de azol como inhibidores de integrina alfa v.
SI3538528T1 (sl) * 2016-11-08 2021-03-31 Bristol-Myers Squibb Company Pirol amidi kot alfa v integrin inhibitorji
MA52117A (fr) * 2017-02-28 2022-04-06 Morphic Therapeutic Inc Inhibiteurs de l'intégrine (alpha-v) (bêta-6)
MA47697A (fr) 2017-02-28 2020-01-08 Morphic Therapeutic Inc Inhibiteurs de l'(alpha-v)(bêta-6) intégrine
BR112020018642A2 (pt) 2018-03-14 2020-12-29 H. Lee Moffitt Cancer Center And Research Institute, Inc. Composto da fórmula i, composição farmacêutica, método de tratamento de câncer em um sujeito em necessidade, método de eliminação de uma célula tumoral em um sujeito
EP4086254B1 (en) 2018-08-29 2024-12-18 Morphic Therapeutic, Inc. Integrin inhibitors
FI3844162T3 (fi) 2018-08-29 2025-03-27 Morphic Therapeutic Inc Alfa v beeta6 -integriinin estäjiä
WO2020047208A1 (en) 2018-08-29 2020-03-05 Morphic Therapeutic, Inc. Inhibitors of (alpha-v)(beta-6) integrin
WO2025067433A1 (zh) * 2023-09-28 2025-04-03 云合智药(苏州)生物科技有限公司 靶向整合素的化合物及其在RNAi剂中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148482B (https=) * 1977-06-03 1981-03-07 Pfizer
EP1306095A3 (en) * 1992-03-05 2003-06-25 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5474765A (en) * 1992-03-23 1995-12-12 Ut Sw Medical Ctr At Dallas Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
US5902795A (en) * 1992-06-16 1999-05-11 Trustees Of Tufts College Oligosaccharides reactive with hyaluronan-binding protein and their methods of use
US5340798A (en) * 1992-10-14 1994-08-23 Merck & Co., Inc. Fibrinogen receptor antagonists
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
US5700801A (en) * 1994-12-23 1997-12-23 Karl Thomae, Gmbh Piperazine derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19613933A1 (de) * 1996-04-06 1997-10-09 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5919792A (en) * 1996-10-30 1999-07-06 Merck & Co., Inc. Integrin antagonists
CA2315232A1 (en) * 1997-12-17 1999-06-24 Merck & Co., Inc. Integrin receptor antagonists
US6211191B1 (en) * 1997-12-17 2001-04-03 Merck & Co., Inc. Integrin receptor antagonists
CA2333647A1 (en) * 1998-06-29 2000-01-06 Dupont Pharmaceuticals Company Cyclic carbamates and isoxazolidines as iib/iiia antagonists
EP1179541B1 (en) * 1999-04-28 2004-06-16 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting VEGF
US6776796B2 (en) * 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device

Similar Documents

Publication Publication Date Title
JP2005539049A5 (https=)
RU2005104115A (ru) Соединения пиперидинила, селективно связывающие интегрины
JP2004516314A5 (https=)
JP2006514003A5 (https=)
JP2019509276A5 (https=)
JP2009532464A5 (https=)
JP2007522098A5 (https=)
JP2015501833A5 (https=)
JP2011518856A5 (https=)
RU2009148796A (ru) Производные пиперидина/пиперазина
ATE286501T1 (de) Pyrimidinderivate
JP2009524676A5 (https=)
RU2005122901A (ru) Производные пиридино [2,3-] пиримидина в качестве селективных ингибиторов kdr и fgfr
JP2013502431A5 (https=)
JP2005500300A5 (https=)
JP2013510825A5 (https=)
RU2014115290A (ru) Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов
JP2011527677A5 (https=)
TW200815410A (en) Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
RU2010136057A (ru) (ДИГИДРО)ПИРРОЛО[2,1-a]ИЗОХИНОЛИНЫ
RU2014135436A (ru) Комбинация ингибитора rtk с антиэстрогеном и ее применение для лечения рака
CN111888329A (zh) 注射剂
JP2013518904A5 (https=)
RU2009119912A (ru) Аминные производные и их применение в бета-2-адренорецептор-опосредованных заболеваний
JP2017522349A5 (https=)